Kidney transplantation provides the optimal survival 1,2 and quality of life 3 for patients with end-stage kidney disease. Socioeconomically disadvantaged patients have previously been found to be less likely to receive kidneys from both living [4] [5] [6] and deceased 7, 8 donors in both the United States and the United Kingdom. Socioeconomic disparities in access to kidney transplantation have been found in high-income countries with universal health care, 9 including Italy 10 and the United Kingdom, 5 and in countries without universal health care, such as the United States. 4 However, this has not been investigated previously in Australia, a country with universal access to health care and a mix of public and private health-care providers. Separate investigations into preemptive, living-donor, and deceased-donor transplantation can highlight what disparities and barriers exist. Furthermore, most studies into socioeconomic status (SES) and access to transplantation have used standard proportional hazard models, with no allowance for competing risks such as death.
We investigated associations between SES and access to transplantation in Australia, with preemptive transplants, and live-and deceased-donor transplants considered separately, as well as potential confounders and covariates, using competing risk regression.
RESULTS
In total, 21,190 patients were included in this study, of whom 4105 had received a kidney transplant in Australia by 31 December 2010. Among primary transplants, 2058 were from living donors and 2047 from deceased donors. The median age at commencement of renal replacement therapy (RRT) was 64 years, and 64% of patients had one or more comorbidities. Patients from disadvantaged areas were slightly younger, but had overall greater comorbidity at commencement of RRT compared with patients from advantaged areas (Table 1) . Living-donor kidneys came from parents (25%), spouses (27%), other relatives (32%), and unrelated donors (16%), and these proportions did not change with SES (w 9 2 ¼ 8, d.f. ¼ 9, P ¼ 0.5). Overall, 660 (3.2%) of incident patients received a preemptive transplant (that is, before any dialysis), and this was more common among patients from advantaged areas. The relative rate (RR) for the most advantaged versus most disadvantaged quartile was 1.93 (95% confidence interval (CI) 1.39-2.68; Po0.001; Figure 1 ). All preemptively transplanted kidneys were from living donors. Waiting time for primary living-donor grafts was much less than for deceased-donor grafts ( Figure 2 ). Patients from the most advantaged quartile were less likely to be referred late to nephrological care ( Table 1 ). The measure of SES used reflects a range of factors including income, education, employment type, and access to information (Figure 3) .
Patients from advantaged postcodes were more likely to receive a non-preemptive transplant from a living donor. The competing risk subhazard ratio (SHR) for the most advantaged when compared with the most disadvantaged quartile of postcodes was 1.34 (95% CI 1.11-1.62, P ¼ 0.002; Figure 2 ). Conversely, SES was not associated with the likelihood of receiving a deceased-donor kidney (SHR ¼ 0.99; 95% CI 0.86-1.14; P ¼ 0.4; Figure 2 ). Adjusting for patient age, demographics, various indicators of health, and late referral made little difference to the effects of SES within competing risk models. Cox models suggested larger associations between SES and deceased-donor transplantation than competing risk models, although both models led to similar conclusions (Table 2 ). There was some association between race and SES among non-Indigenous RRT patients-the proportion of Caucasian patients was highest in the second and third quartiles, but there was no overall trend when analyzed with SES quartiles as a continuous variable (w 3 2 ¼ 0.5, P ¼ 0.5). For completeness, we repeated all analyses with Indigenous Australians included, and found that this made very little difference to associations between SES and transplantation. Similarly, including each comorbidity as a separate covariate made no discernible difference to the results.
Patient demographics, health, and gender
Advanced age, presence of comorbidities, type of primary kidney disease, and smoking status were all associated with decreased likelihood of receiving any type of kidney graft (Po0.002, Figure 4 ). SES had a marginally larger effect on patients aged 18-39 years at commencement of RRT rather than older patients, who were unlikely to receive a preemptive transplant regardless of SES (w 2 2 ¼ 5, P ¼ 0.08 for the age category: SES interaction; Figure 1 ).
Patients with comorbidities were considerably less likely to receive any type of transplant ( Figure 4 ). There were no significant interactions between SES and comorbidity burden, race, remoteness, state, previously diagnosed cancer, or body mass index category on the likelihood of receiving a preemptive transplant (P40.2).
There was no gender disparity in access to preemptive transplants (P ¼ 0.9, Figure 4 ). Males were more likely to receive a non-preemptive transplant with a living-donor kidney (RR ¼ 1.22, 95% CI 1.09-1.37; Po0.0007) or a Patients living outside major cities were more likely to receive a preemptive (P ¼ 0.02) or subsequent living-donor graft (Po0.0001), but less likely to receive a deceased-donor kidney (P ¼ 0.03; Figure 4 ). There was no significant interaction between urban/rural location and SES in the likelihood of receiving a preemptive transplant (w 1 2 ¼ 0.34, P ¼ 0.6). Advantaged postcodes were more likely to be in major cities (w 3 2 ¼ 619, Po0.001). Only 7% of postcodes outside of major cities were in the most advantaged quartile, compared with 54% of postcodes within major cities.
DISCUSSION
Patients from advantaged areas were more likely to receive a graft from a living donor, both before and after commencement of dialysis. However, SES was not associated with the likelihood of receiving a kidney from a deceased donor. Younger, healthier patients, nonsmokers, and males were more likely to receive a transplant from any source, and patients from disadvantaged areas generally had more comorbidities and higher prevalence of smoking and obesity. The relationship between SES and transplantation has not changed significantly since 2000.
Socioeconomic disadvantage is likely to pose a range of barriers to receiving a living-donor kidney. Donors and recipients must be medically suitable and the burden of morbidity is greater and harmful health-related behaviors more common among people who live in disadvantaged areas. [11] [12] [13] [14] [15] Although higher levels of comorbidity (or underreporting and thus underadjustment for comorbidities within models) within potential recipients may be important, this is not likely to be a factor, given the absence of a SES-related trend for deceased-donor transplants. Disadvantaged areas have proportionally more single parents, 16 and parents provided 25% of living-donor kidneys. However, we found no evidence that the makeup of donor/recipient relationships varied with SES. Patients from advantaged areas are more likely to have timely referral to nephrological care, 17 and latereferred patients are less likely to receive a kidney transplant; 18 however, adjusting for late referral made little difference to SES gradients.
Patient education is determined by individual transplanting hospitals, and there is likely also to be some education by nephrologists from referring centers, dialysis nursing staff, and a number of others. Although patient education is a strong determinant of access to transplantation, especially in the United States, 19 the ANZDATA Registry does not collect data on this. There is no standard pretransplant assessment process in Australia, and ANZDATA (Australia and New Zealand Dialysis and Transplant Registry) does not collect details of any referral for transplantation or workup. It is possible that advantaged patients receive earlier care and pretransplant workup, which may be one factor leading to more preemptive transplants. Potential donors with limited financial resources may not be able to afford time off work or away from family commitments to undergo workup or nephrectomy. 20 They may also face direct costs related to testing and transport to hospitals, and may have reduced family and social support perioperatively. Patients may also be less willing to approach potential donors for fear of causing financial burden. 21 There is no specific compensation for kidney donors beyond standard sick leave entitlements (typically 2 weeks per year), or out-of-pocket medical and related expenses. One state (Western Australia) introduced a system for reimbursing living donors for expenses related to travel, accommodation, and meals in 2006, 22 and preliminary analyses suggest an increase in preemptive transplantation rates in this state around this time (data not shown). The United Kingdom has provisions for reimbursing donors, but these may not be applied uniformly. 6 We found no association between SES and likelihood of receiving a kidney from a deceased donor in Australia. This is a crucial difference in findings from this study compared with results from the United States 4 and United Kingdom, 7, 8 which have shown reduced access to both living-and deceaseddonor transplants for disadvantaged patients. These differences may be because of variation in the structure of healthcare systems, subsidies, algorithms used to allocate deceaseddonor kidneys, and other factors that cannot be quantified with registry data. The process for allocating deceased-donor kidneys in Australia gives considerable weight to time spent on waiting list. 23 Australia provides universal access to government-funded health care, whereas disadvantaged US citizens are less likely to have insurance, and may face significant out-of-pocket costs for many services. Australians from advantaged areas are more likely to have additional health insurance and are more likely to receive additional screening and elective surgery, 24 as well as improved access to specialist and allied health care. This may explain lower rates of late referral in advantaged areas. Socioeconomic disparities in uptake of health care have been implicated in higher rates of end-stage kidney disease among disadvantaged Australians, 25 as has been found for other diseases. 26 The United Kingdom also provides universal access to health care, but still has socioeconomic disparities in access to kidney transplantation for deceased-donor kidneys, 5, 8, 27 suggesting that other barriers exist for disadvantaged people in the United Kingdom. Kidney transplantation is only performed in publicly funded hospitals in Australia.
For US patients, transplantation results in more out-ofpocket costs for patients than dialysis, which may deter some disadvantaged patients. 28 Many US patients lose Medicare funding for immunosuppressive drugs 3 years after transplantation, 4 whereas Australian and UK transplant recipients receive subsidized immunosuppressive drugs for the life of the graft, although they still face some out-of-pocket expenses for these medications. These expenses (and entitlements) are similar to those faced by patients on dialysis.
Papers investigating disparities in access to transplantation have used different starting points, end points, or analytical techniques. Studies from the United States often investigate access to waiting lists, 7, 19 or transplantation among patients who are placed on the waiting list. 4, 29 However, time from commencing dialysis to receiving a transplant is the important determinant of patient health. For this reason, researchers from other countries often analyze time from commencing RRT to receiving a transplant. 8, 30 Although such differences make international comparisons difficult, access to transplantation among US patients on the waiting list was similar to our current results for Australian patients on RRT. 4 Hall et al. 29 found that much of the racial differences in access to transplantation in the United States was because of variation in transplantation rates of patients who were waitlisted.
One key strength of this analysis is that we used competing risk regression, whereas most investigations in this field have used Cox survival models, which assume that censored patients are similar to those who remain in the analysis pool. In an analysis of deceased-donor transplants, patients would be censored in a Cox proportional hazard models if they received a living-donor kidney, despite patients who receive a living-donor kidney being generally younger, healthier, and coming from more advantaged areas. Treating such patients as identical to those who remain on the waiting list for deceased-donor kidneys would violate assumptions of independent censoring. This informative censoring often results in Cox models producing inflated estimates. Choice of model made no real difference to analyses of living-donor transplantation, where there were few competing events (few deaths or deceased-donor transplants before living-donor transplants). However, Cox models produced inflated adjusted hazard ratios for SES advantage, and did not detect differences between major cities and more remote areas in access to deceased-donor kidneys, whereas competing risk models did detect such trends. Despite the use of competing risk models, we cannot rule out the possibility that interactions between living-donor and deceased-donor transplantation may reduce apparent associations between deceased-donor transplants and SES. The comparatively high rate of living-donor transplants among advantaged patients may mean that many suitable patients from advantaged areas are unlikely to receive a deceased-donor transplant.
Our analyses demonstrated differences in access to transplantation between states, and within states, as well as remoteness, which deserve further investigation. However, the effects of SES were consistent between states. Most kidneys are transplanted in the same state that they were donated, 31 and the Australian deceased-donor kidney allocation process ensures that each state receives the same number of kidneys as they contribute to the pool. As there is substantial variation in the deceased-donor rates between states, much of the variation between states may reflect the availability of kidneys. This paper focused on SES, and these geographical variations warrant separate detailed investigation.
Some potential barriers to transplantation cannot be ascertained with registry data, such as patient knowledge and education about transplantation, which have been identified as a barrier to deceased-donor transplantation in the United States. 32 Educating suitable dialysis patients about transplantation reduced racial disparities in time to waitlisting. 19 In addition, determining whether a patient is suitable for transplantation is often subjective, 32, 33 and SES disparities may exist at this step in Australia. This study has several strengths: the completeness and national coverage of the ANZDATA registry, completeness of postcode records, the size of the sample, the use of standardized SES indices, and the use of competing risk regressions that allow systematic analyses of both live-and deceased-donor transplantation. The major limitation of this study is that postcode-level data were the only SES indices available from the ANZDATA registry. Such Australian postcode-level SES indices can be reliable, and are regularly used, estimates of individual SES. 34 Area-level SES also predicts health independently of individual-level SES. 26, 35 Compared with the US ZIP codes, Australian postcodes are considerably smaller, possibly making them more accurate estimates of individual-level SES, although increased SES heterogeneity within remote postcodes may confound some results. Unmeasured or incompletely measured covariates, such as comorbidity, may contribute to associations between SES and transplantation. Blood group and human leukocyte antigen panel reactive antibody measures are likely to be important covariates, but may not be strongly correlated with SES. 36 However, SES was not associated with access to deceased-donor grafts, suggesting that SES may have a true effect and not due to underadjustment for confounders.
In these analyses, we found no association between SES and access to kidneys from deceased donors in Australia. This is reassuring, given that these are a scarce societal resource. Australians from advantaged areas were, however, more likely to receive a kidney from a live donor (both for preemptive and subsequent transplants). Financial barriers (especially for donors) and higher rates of comorbidities may preclude family members from becoming living donors. If rates of livekidney transplantation are to be increased for disadvantaged Australians, future research must clearly identify such barriers.
MATERIALS AND METHODS Patients
Patients aged X18 years, who were recorded in the ANZDATA Registry as commencing RRT (chronic dialysis or kidney transplantation) in Australia in 2000-2010, were included in this study. ANZDATA has complete coverage of all dialysis and transplantation centers in Australia, and all patients are included in the registry unless they specifically request otherwise. Patients were excluded if they received a transplant outside of Australia (N ¼ 19), they received any organ in addition to a kidney (N ¼ 274), or if they selfreported as being Indigenous Australians (N ¼ 2166). The markedly reduced transplant access experienced by Indigenous Australians 37 might confound the effect of SES, and the requirement for many Indigenous patients to relocate before commencing RRT would undermine the reliability of area-based estimates of SES. 38 
Outcomes
We investigated the proportions of patients who received a preemptive kidney transplant (that is, before any dialysis). Among patients who commenced dialysis before receiving a transplant, we investigated time from commencing dialysis to receiving a primary transplant, and whether this was from a living or a deceased donor.
Predictors
We used Australian postcode (analogous to US ZIP code) as area units. In 2006, Australian postcodes had a median population of 3323 people (interquartile range of 788-11,351), which is fewer than US ZIP codes or census tracts. Postcodes were ranked using the Australian Bureau of Statistics' Index of Relative Advantage and Disadvantage, similar to previous studies into associations between SES and RRT. 39 This index is derived from 2006 census data on income, education, employment status, occupation type, housing, internet access, disability status, car ownership, and single parent status. 40 Postcodes were divided into quartiles of SES, with quartile 1 being the most disadvantaged. Forty-nine patients (o0.3%) were excluded because of difficulties in matching residential postcodes in ANZDATA to those used by the Bureau of Statistics. Each postcode was assigned a remoteness index-either major city or other (regional, remote, or very remote)-using Australian Standard Geographical Classification, 2006. 41 
Analyses
All analyses were conducted with the following as covariates: age group (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) , and 60 þ years), gender, body mass index (o18.5, 18.5-24.9, 25-29.9, and 30 þ kg/m 2 ), smoking status, number of comorbidities (diabetes, chronic lung disease, coronary artery disease, peripheral vascular disease, and cerebrovascular disease), primary kidney disease, racial origin (self-reported Caucasian vs. other non-Indigenous), state of residence, late referral, and whether their postcode corresponded to a major city. Primary kidney diseases were grouped into four categories: diabetes and hypertension; glomerulonephritis; polycystic kidney disease; and all others. Australian states and territories were grouped according to transplant region. 23 Patients who were referred to nephrological care within 3 months of commencing RRT were considered to be 'late referrals.' Unadjusted analyses were also included for comparison.
Demographic factors were compared between advantaged and disadvantaged postcodes using either w 2 tests (gender, race, comorbidities, smoking, and kidney disease late referral) or Mann-Whitney U-tests.
We used Poisson regression, with variance clustered by treating hospital, to investigate RRs (which are analogous to relative risks for binary outcomes) for patients receiving a preemptive transplant (transplant as the first mode of RRT) between quartiles of area SES. 42 This was repeated, including interactions between SES and gender, age group, number of comorbidities, race (Caucasian vs. The likelihood of receiving the first kidney transplant over time was analyzed using competing risk proportional subhazard models on time from commencing RRT to receiving a transplant, using the method of Fine and Gray. 43 Patients who received preemptive transplants were not included to avoid violating the assumption of constant proportional hazards. The 'risk' of receiving a kidney from a living donor was modeled with patient death and deceased-donor transplantation as competing risks. Similarly, the risk of receiving a deceased-donor kidney was modeled with death and living-donor transplantation as competing risks. Results are expressed as SHRs, which are analogous to hazard ratios produced by Cox regressions. For comparison, survival analyses were repeated using Cox proportional hazard models, and with Indigenous Australians included. The assumption of constant proportional subhazards was checked by plotting Shoenfeld-like residuals and by investigating a SES: time interaction term within the model. Cumulative incidence graphs were produced using nonparametric techniques. 44 Among patients who received living-donor transplants, the relationship between donor and recipient (parent, spouse, other relative, or nonrelative) was compared between quartiles of postcodes using Pearson's w 2 test. Unless stated explicitly, all values for RR and SHRs are adjusted and presented with 95% CIs. All analyses were conducted using Stata 12 IC (StataCorp, College Station, TX).
